Downregulating testosterone levels enhance immunotherapy efficiency.
Oncoimmunology. 2021 Sep 27;10(1):1981570. doi: 10.1080/2162402X.2021.1981570. eCollection 2021.
Oncoimmunology. 2021.
PMID: 34595060
Free PMC article.